-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Syndax Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to Q3 2025.
- Syndax Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 86.6M shares, a 1.39% increase year-over-year.
- Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 85.6M shares, a 21.7% increase from 2023.
- Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 70.4M shares, a 15.8% increase from 2022.
- Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.8M shares, a 13.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)